Financial News · Live Terminal

Page 347 of 417

TD Cowen Initiates Mineralys Therapeutics at Buy

Mineralys Therapeutics (MLYS) has an average rating of buy and mean price target of $49.38, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)

Financial News · Live Terminal

TD Cowen Initiates Mineralys Therapeutics at Buy

Benchmark Initiates DDC Enterprise at Buy With $3 Price Target

Wells Fargo Upgrades OGE Energy to Equal Weight From Underweight, Adjusts PT to $47 From $42

Stifel Initiates HMH Holding at Buy With $27 Price Target

Oppenheimer Downgrades Terns Pharmaceuticals to Market Perform From Outperform

Wells Fargo Downgrades Kinsale Capital Group to Equalweight From Overweight, Adjusts Price Target to $357 From $420

Update: Chardan Initiates Riot Platforms at Buy With $27.50

JPMorgan Initiates Coverage on Matson With Overweight Rating, $230 Price Target

Chardan Initiates Keel Infrastructure at Buy With $4.50 Price Target

JPMorgan Initiates Coverage on Powell Industries With Overweight Rating, $310 Price Target

Northland Downgrades Advanced Micro Devices to Market Perform From Outperform

HC Wainwright Initiates Coverage on LB Pharmaceuticals With Buy Rating, $45 Price Target

HC Wainwright Initiates Coverage on NervGen Pharma With Buy Rating, $18 Price Target

Jefferies Initiates Coverage on Rubrik With Buy Rating, $65 Price Target

Chardan Initiates Riot Platforms at Buy

Jefferies Initiates Coverage on Commvault Systems With Hold Rating, $105 Price Target

Jefferies Initiates Coverage on Cohu With Buy Rating, $55 Price Target

Chardan Initiates Galaxy Digital at Buy With $35 Price Target

KeyBanc Upgrades Comfort Systems USA to Overweight From Sector Weight, Sets $2,004 Price Target

Raymond James Upgrades First Bancorp to Strong Buy From Outperform, Lifts Price Target to $27 From $26

TD Cowen Initiates Mineralys Therapeutics at Buy

Benchmark Initiates DDC Enterprise at Buy With $3 Price Target

Wells Fargo Upgrades OGE Energy to Equal Weight From Underweight, Adjusts PT to $47 From $42

Stifel Initiates HMH Holding at Buy With $27 Price Target

Oppenheimer Downgrades Terns Pharmaceuticals to Market Perform From Outperform

Wells Fargo Downgrades Kinsale Capital Group to Equalweight From Overweight, Adjusts Price Target to $357 From $420

Update: Chardan Initiates Riot Platforms at Buy With $27.50

JPMorgan Initiates Coverage on Matson With Overweight Rating, $230 Price Target

Chardan Initiates Keel Infrastructure at Buy With $4.50 Price Target

JPMorgan Initiates Coverage on Powell Industries With Overweight Rating, $310 Price Target

Northland Downgrades Advanced Micro Devices to Market Perform From Outperform

HC Wainwright Initiates Coverage on LB Pharmaceuticals With Buy Rating, $45 Price Target

HC Wainwright Initiates Coverage on NervGen Pharma With Buy Rating, $18 Price Target

Jefferies Initiates Coverage on Rubrik With Buy Rating, $65 Price Target

Chardan Initiates Riot Platforms at Buy

Jefferies Initiates Coverage on Commvault Systems With Hold Rating, $105 Price Target

Jefferies Initiates Coverage on Cohu With Buy Rating, $55 Price Target

Chardan Initiates Galaxy Digital at Buy With $35 Price Target

KeyBanc Upgrades Comfort Systems USA to Overweight From Sector Weight, Sets $2,004 Price Target

Raymond James Upgrades First Bancorp to Strong Buy From Outperform, Lifts Price Target to $27 From $26